Floatz logo

PREDNISONE TABLETS

Untreated

The First Affiliated Hospital with Nanjing Medical UniversitySmall moleculePhase 1/2Active
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
89/ 100

Competitive context

10 Active assets in the Untreated cohort.

Asset / SponsorPhaseRating
Inno-206
The First Affiliated Hospital with Nanjing Medical University
Phase 2BB
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
The First Affiliated Hospital with Nanjing Medical University
Phase 2B
(+)-VINCRISTINE
The First Affiliated Hospital with Nanjing Medical University
Phase 2B
cc-5013
The First Affiliated Hospital with Nanjing Medical University
Phase 2B
Cyclophosphamide
The First Affiliated Hospital with Nanjing Medical University
Phase 2B

View all 12 →

Same molecule, other indications

PREDNISONE TABLETS is also rated in:

Recurrent Adult T-cell Leukemia/LymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
diffuse large B-cell lymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
metastatic prostate carcinomaDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →